Patent details

Basic Information

Publication number:

EP3190127

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171592538

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

French

English Title of Invention:

USE OF AN ANTIBODY DIRECTED AGAINST BDCA-2 FOR THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISORDERS

French Title of Invention:

UTILISATION D'UN ANTICORPS DIRIGE CONTRE BDCA-2 POUR TRAITER DES MALADIES AUTO-IMMUNES OU INFLAMMATOIRES

German Title of Invention:

ERWENDUNG EINES ANTIKÖRPERS GEGEN BDCA-2 FÜR DIE BEHANDLUNG VON AUTOIMMUNE ODER ENTZÜNDUNGSKRANKHEITEN

SPC Number:

Dates

Filing date:

12/12/2011

Grant date:

07/10/2020

EP Publication Date:

12/07/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/10/2020

EP B1 Publication Date:

07/10/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/12/2020

Expiration date:

12/12/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/09/2020

 

 

Name:

Laboratoire Français du Fractionnement et des Biotechnologies

Address:

ZA de Courtaboeuf 3, avenue des Tropiques, 91940 Les Ulis, France (FR)

Inventor

1

Name:

DE ROMEUF, Christophe

Address:

France (FR)

2

Name:

FOURNIER, Nathalie

Address:

France (FR)

Priority

Priority Number:

1060428

Priority Date:

13/12/2010

Priority Country:

France (FR)

Classification

IPC classification:

A61K 39/395; A61P 35/00; A61P 37/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202041

Publication date:

07/10/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages